LEP and cancer: In addition, leptin and adipocyte-derived IL-6 enhance the expression of lysyl hydroxylase (PLOD2) by activating the JAK/STAT3 and PI3K/AKT signaling pathways, ultimately facilitating cancer cell metastasis (103–106).